Tumor component proportion determines the prognosis of patients with combined hepatocellular-cholangiocarcinoma

Hepatobiliary and Pancreatic Diseases International · Published 2026-06-01 · DOI 10.1016/j.hbpd.2026.06.004

Authors (8)

Han Wang, You-Wen Qian, Xia Sheng, Chun-Yan Xia, Ying-Ying Zhou, Wen-Ming Cong, Miao-Xia He, Hui Dong

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wang, H., Qian, Y., Sheng, X., et al. (2026). Tumor component proportion determines the prognosis of patients with combined hepatocellular-cholangiocarcinoma. Hepatobiliary and Pancreatic Diseases International. https://doi.org/10.1016/j.hbpd.2026.06.004

Related articles

• Meetings and Courses · Hepatobiliary and Pancreatic Diseases International · 2026 · Same journal
• A rare case of emphysematous liver abscess · Hepatobiliary and Pancreatic Diseases International · 2026 · Same journal
• Meetings and Courses · Hepatobiliary and Pancreatic Diseases International · 2026 · Same journal
• Non-physiological renoportal anastomosis during liver transplantation in a patient with Yerdel grade 4 portal vein thrombosis · Hepatobiliary and Pancreatic Diseases International · 2026 · Same journal
• Neutrophil percentage-to-albumin and carbohydrate antigen 19-9 stratified score predicts postoperative recurrence in biliary tract cancer · Hepatobiliary and Pancreatic Diseases International · 2026 · Same journal
• Exosome-delivered miR-769-3p promotes malignant progression of hepatocellular carcinoma via ALKBH5-dependent m6A modification · Hepatobiliary and Pancreatic Diseases International · 2026 · Same journal
• Yttrium-90 downstages giant hepatocellular carcinoma to resectable size · Hepatobiliary and Pancreatic Diseases International · 2026 · Same journal
• Timing of endoscopic retrograde cholangiopancreatography in acute cholangitis: A cohort study in Colombia · Hepatobiliary and Pancreatic Diseases International · 2026 · Same journal
• Cost-effectiveness of ivosidenib in patients with previously treated isocitrate dehydrogenase 1 (IDH1)-mutant cholangiocarcinoma: An Italian perspective · Hepatobiliary and Pancreatic Diseases International · 2026 · Same journal
• Machine perfusion improves outcomes of liver recipients via non-immunomodulatory effects · Hepatobiliary and Pancreatic Diseases International · 2026 · Same journal